tirbanibulin Cream 2.5 mg/250 mg
Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP
Manufacturer #13215
A research-driven pharmaceutical manufacturer committed to developing and commercialising innovative pharmaceutical products for patients worldwide, with a specialty focus on medical solutions for skin-related conditions. The organisation highlights strong scientific innovation, an active R&D pipeline, and collaboration/open-innovation partnerships to advance new therapies, positioning its pharmaceutical products portfolio around improving long-term outcomes in its core specialty areas.
Manufacturer usually replies in 108 days